课题基金 / 基金详情

REVERSING EPITHELIAL TO MESENCHYMAL TRANSITION BY TARGETED EPIGENETIC EDITING IN BREAST CANCER

REVERSING EPITHELIAL TO MESENCHYMAL TRANSITION BY TARGETED EPIGENETIC EDITING IN BREAST CANCER
通过靶向表观遗传编辑在乳腺癌中逆转上皮细胞向间质细胞的转变
批准号:
nhmrc : GNT1147528
负责人:
A/Pr Andrew Redfern
金额:
$133.37万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2018
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2018-01-01 至 --

项目摘要

项目成果

A/Pr Andrew Redfern的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cancer cell spread around the body involves changes in the cells which allow them to migrate into blood vessels, travel and then invade other organs, a process called epithelial mesenchymal transition (EMT). EMT also makes cells less sensitive to our best treatments. EMT involves switching on genes that activate these changes and switching off genes that silence them. We will develop therapy that will reverse this process, both reducing cancer spread and making cancer treatment more effective.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
REVERSING EPITHELIAL TO MESENCHYMAL TRANSITION BY TARGETED EPIGENETIC EDITING IN BREAST CANCER
  • 批准号:
    nhmrc : 1147528
  • 项目类别:
    Project Grants
  • 资助金额:
    $90.17万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Andrew Redfern
  • 依托单位:
Activation of BMP4 signalling to inhibit breast cancer metastasis
  • 批准号:
    nhmrc : GNT1121199
  • 项目类别:
    Project Grants
  • 资助金额:
    $74.87万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Andrew Redfern
  • 依托单位:
Activation of BMP4 signalling to inhibit breast cancer metastasis
  • 批准号:
    nhmrc : 1121199
  • 项目类别:
    Project Grants
  • 资助金额:
    $51.15万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Andrew Redfern
  • 依托单位:
CHARACTERIZATION OF A NEW SUBTYPE OF AGGRESSIVE BREAST CANCER
  • 批准号:
    nhmrc : GNT1130212
  • 项目类别:
    Project Grants
  • 资助金额:
    $76.32万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Andrew Redfern
  • 依托单位:
海外基金